Maria Angeles
Maria Angeles Abengozar Infantes, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130287795 | ANTI-EPHRIN-B2 ANTIBODY AND USE THEREOF - The present invention relates to a novel antibody against ephrin B2 and its use to detect the protein and as a medicament for inhibiting angiogenesis and lymphangiogenesis in the treatment of diseases in which these processes are implicated, for example, cancer. | 10-31-2013 |
Maria Angeles Alava Martinez De Contrasta, Zaragosa ES
Patent application number | Description | Published |
---|---|---|
20120189690 | Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein - The invention relates to the field of biotechnology and medicine. The invention specifically relates to a compound comprising a liposome covered or decorated at least with the extracellular domain of the APO2L/TRAIL protein, and to the use thereof far developing a medicament preferably for the treatment of a cancer or inflammatory or autoimmune diseases, such as rheumatoid arthritis. | 07-26-2012 |
Maria Angeles Bonet Aracil, Alcoi ES
Patent application number | Description | Published |
---|---|---|
20100183690 | Insect Repellent Textile - Disclosed embodiments include a textile with insect repellent properties comprising (a) a natural or synthetic fabric, (b) a microencapsulated active ingredient having insect repellent properties, and (c) a resin solution to attach said microencapsulated active ingredients to the fabric. According to a particular embodiment, and without limitation, the insect repellent textile uses a resin solution with a concentration designed to control the degree of wash fastness and gradual release of the microencapsulated active ingredient embedded in the textile in order for it to be gradually released by skin pressure and friction. A plurality of microencapsulated active ingredients could be used including microencapsulated permethrin or toluamide. | 07-22-2010 |
Maria Angeles Callejo Rodriguez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20130135992 | METHOD AND SYSTEM FOR MANAGING HIGH CAPACITY TRAFFIC OFFLOAD IN AN IP NETWORK NUCLEUS IN THE TRANSPORT LAYER - The invention relates to a method and system for coordinating and automating the processes of IP traffic offload in transport technology, minimizing the operational problems associated with the configuration of IP and transport layers. The system consists of two main components, a transit traffic management module integrated into a network operator and a routing module for generating new links integrated into each of the IP network nodes. | 05-30-2013 |
Maria Angeles Cubillo De Dios, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090209522 | Heterocyclic Non-Peptide GNRH Antagonists - A compound of formula (I): wherein either B is absent and A and Z are the same or different and are each hydrogen, halogen, alkyl, hydroxy, alkoxy, —CN, —C(R | 08-20-2009 |
Maria Angeles Fisas Escasany, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20100280072 | 2-'4-(HYDROXYMETHYL-PHENYLAMINO) -PIPERIDINE-1-YL!-N- (9H-CARBAZOL-3YL) - ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY - The present invention relates to 1,4-disubstituted piperidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the preparation of a medicament for the treatment of humans or animals. The substituents are as defined in the present claim | 11-04-2010 |
20110172270 | 2-'4(PHENYLAMINO)-PIPERIDIN-1-YL!-N-PHENYL-ACETAMINE DERIVATIVES AND RELATED COMPOUNDS AS NEUROPEPTIDE Y5 (NPY5) LIGANDS FOR THE TREATMENT OF OBESITY - 1,4-disubstituted piperidine compounds of general formula (I) wherein the substituents are defined in claim | 07-14-2011 |
Maria Angeles Gomez Ruiz, Grimbergen DE
Patent application number | Description | Published |
---|---|---|
20110259365 | LIQUID DETERGENT COMPOSITION - A method of cleaning dishware with a liquid detergent composition having an amphiphilic graft polymer, to provide improved grease cleaning and sudsing. | 10-27-2011 |
Maria Angeles Gomez Ruiz, Grimbergen BE
Patent application number | Description | Published |
---|---|---|
20080300158 | LIQUID DETERGENT COMPOSITION - A method of cleaning dishware with a liquid detergent composition having an amphiphilic graft polymer, to provide improved grease cleaning and sudsing. | 12-04-2008 |
20090186796 | LIQUID DETERGENT COMPOSITION - The present invention relates to a light duty liquid detergent composition comprising a low molecular weight hydrophobically modified cellulosic polymer, to provide improved foaming properties. | 07-23-2009 |
Maria Angeles Gutierrez Garcia, Vizcaya ES
Maria Angeles Lavia Gonzalez-Escalada, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090107848 | Procedure for anodising aluminium or aluminium alloys - This invention refers to a procedure for anodising aluminium or aluminium alloys in which an aluminium or an aluminium alloy part is submerged an in an aqueous solution at a temperature between 0° C. and 140° C., preferably between 0° C. and 130° C., in which said solution includes: | 04-30-2009 |
Maria Angeles Martinez Vargas, Zurich CH
Patent application number | Description | Published |
---|---|---|
20120234718 | PHARMACEUTICAL FORMULATION FOR USE IN SPINAL FUSION - A pharmaceutical formulation for use in a spinal fusion method, comprising a composition for forming a matrix, a kit comprising the composition, a pharmaceutical product obtainable from the pharmaceutical formulation, and an interbody spinal fusion cage containing the pharmaceutical formulation or the pharmaceutical product are described herein. The composition comprises at least a first matrix material precursor component and a second matrix material precursor component that are able to crosslink to form the matrix under appropriate conditions, a bioactive factor that is biologically active for stimulating bone formation between two vertebrae and for effecting or supporting spinal fusion. The bioactive factor is PTH, optionally a PTH fusion peptide. The bioactive factor is releasably incorporated in the matrix upon crosslinking of the matrix material precursor components. | 09-20-2012 |
Maria Angeles Muñoz Fernandez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090208929 | Method Of In-Vitro Detection And Quantification Of HIV DNA By Quantitative PCR - Process for the detection and quantification in-vitro of HIV DNA by quantitative PCR. The invention consists of developing pairs of oligonucleotides capable of hybridizing with fragments of the gag gene sequence present in the genome of the HIV virus. These oligonucleotides permit amplification of the viral DNA by quantitative PCR. Even in the case of samples with low viral load, the invention permits detection of the HIV DNA virus by juxtaposition either of a conventional PCR with a quantitative PCR, or with a double nested quantitative PCR, using different pairs of primers in each amplification. The invention, compared with the known methods, allows determining qualitatively and quantitatively, in-vitro, the presence of HIV DNA in samples, in a rapid, reproducible manner and with high sensitivity. | 08-20-2009 |
Maria Angeles Muñoz Fernandez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20090208929 | Method Of In-Vitro Detection And Quantification Of HIV DNA By Quantitative PCR - Process for the detection and quantification in-vitro of HIV DNA by quantitative PCR. The invention consists of developing pairs of oligonucleotides capable of hybridizing with fragments of the gag gene sequence present in the genome of the HIV virus. These oligonucleotides permit amplification of the viral DNA by quantitative PCR. Even in the case of samples with low viral load, the invention permits detection of the HIV DNA virus by juxtaposition either of a conventional PCR with a quantitative PCR, or with a double nested quantitative PCR, using different pairs of primers in each amplification. The invention, compared with the known methods, allows determining qualitatively and quantitatively, in-vitro, the presence of HIV DNA in samples, in a rapid, reproducible manner and with high sensitivity. | 08-20-2009 |
Maria Angeles Pasamar Fernandez, Valencia ES
Patent application number | Description | Published |
---|---|---|
20100062138 | PROCESS FOR OBTAINING POLYPHENOL-RICH COCOA POWDER WITH LOW FAT CONTENT AND COCOA THUS OBTAINED - The invention relates to a method for obtaining polyphenol-rich cocoa powder with a low fat content and to the cocoa thus obtained. The method optionally includes a phase comprising the purification of the polyphenols obtained from the defatted cocoa cake using an Amberlite column. The end product has a particle size of less than 3 mm for 99% of the particles and a polyphenol content of preferably between 60 and 90% and a fat content of less than 12% in relation to the weight of the dry matter. | 03-11-2010 |
Maria Angeles Rol De Lama, Murcia ES
Patent application number | Description | Published |
---|---|---|
20140187871 | DEVICE WHICH COMPRISES A PHYSICAL ACTIVITY AND POSITION SENSOR, A PERIPHERAL TEMPERATURE SENSOR AND A LIGHT SENSOR FOR PROVIDING INFORMATION RELATING TO THE STATE OF THE CIRCADIAN SYSTEM - The invention is a device consisting of at least one body position and activity sensor, at least one peripheral temperature sensor and at least one light sensor, configured to provide information on the circadian system status and the sleep-wake status of an individual based on the data obtained from said sensors. It can be placed on the wrist of the subject, or on the subject's arm. The device may also include a blood pressure sensor. This device may be used in general studies of the human circadian system and, more specifically, for the study of sleep-wake and blood pressure rhythms. | 07-03-2014 |
Maria Angeles Solinis Aspiazu, Leioa ES
Patent application number | Description | Published |
---|---|---|
20130324592 | Lipid Nanoparticles for Treating Ocular Diseases - The present invention relates to the use of a lipid nanoparticle system, where the nanoparticles comprise a nucleic acid, a lipid component, a cationic surfactant, a non-ionic surfactant, a polysaccharide, and optionally a positively charged peptide for the treatment and prevention of eye diseases. | 12-05-2013 |
Maria Angeles Solinís Aspíazu, Leioa - Vizcaya ES
Patent application number | Description | Published |
---|---|---|
20120183589 | Lipid Nanoparticles For Gene Therapy - The present invention relates to a lipid nanoparticle system comprising a lipid component, a cationic surfactant, a non-ionic surfactant, a polysaccharide and, optionally, a positively charged peptide, useful for the release of pharmacologically active molecules, and especially for transfecting genetic material into cells and/or tissues. It also relates to methods for obtaining nanoparticles, to pharmaceutical compositions comprising it, as well as to the use thereof in gene therapy. | 07-19-2012 |